摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-5-(2-Mesyloxyethyl)-2,2-dimethyl[1,3]dioxolan-4-one | 188908-62-5

中文名称
——
中文别名
——
英文名称
(S)-5-(2-Mesyloxyethyl)-2,2-dimethyl[1,3]dioxolan-4-one
英文别名
2-[(4S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl]ethyl methanesulfonate
(S)-5-(2-Mesyloxyethyl)-2,2-dimethyl[1,3]dioxolan-4-one化学式
CAS
188908-62-5
化学式
C8H14O6S
mdl
——
分子量
238.262
InChiKey
BAKGJYVYYDSFDL-LURJTMIESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    87.3
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Selective MMP inhibitors having reduced side-effects
    申请人:——
    公开号:US20020035065A1
    公开(公告)日:2002-03-21
    The subject invention pertains to matrix metalloproteinase (MMP) inhibitors that exhibit an IC 50 of below 10 −4 M against MMP and have substantially no activity against non-MMP metalloproteinase-related events. The MMP inhibitors of the invention have reduced side-effects, especially with respect to joint pain.
    本发明涉及一种针对基质金属蛋白酶(MMP)的抑制剂,其对MMP的IC50低于10^-4M,并且几乎不对非MMP金属蛋白酶相关事件产生活性。本发明的MMP抑制剂具有减少的副作用,尤其是关节疼痛方面。
  • [EN] SELECTIVE MMP INHIBITORS HAVING REDUCED SIDE-EFFECTS<br/>[FR] INHIBITEURS SELECTIFS DE LA METALLOPROTEASE MATRICIELLE PRESENTANT DES EFFETS SECONDAIRES REDUITS
    申请人:DARWIN DISCOVERY LIMITED
    公开号:WO1998039024A1
    公开(公告)日:1998-09-11
    (EN) A matrix metalloproteinase (MMP) inhibitor that exhibits an IC50 of below 10-4M against MMP and has substantially no activity against non-MMP metalloproteinase-related events has reduced side-effects, especially with respect to joint pain.(FR) L'invention concerne un inhibiteur de la métalloprotéase matricielle qui présente une concentration inhibitrice 50 de moins de 10-4M contre la métalloprotéase matricielle, et n'exerce sensiblement aucune activité contre les évènements non liés à la métalloprotéase matricielle. Cet inhibiteur présente des effets secondaires réduits, en particulier, dans le domaine des douleurs articulaires.
    一种基质金属蛋白酶(MMP)抑制剂,对MMP的IC50低于10-4M,并且几乎没有对非MMP金属蛋白酶相关事件的活性,具有减少副作用的作用,尤其是对关节疼痛方面的作用。
  • EP2230239
    申请人:——
    公开号:——
    公开(公告)日:——
  • SELECTIVE MMP INHIBITORS HAVING REDUCED SIDE-EFFECTS
    申请人:Darwin Discovery Limited
    公开号:EP0981366B1
    公开(公告)日:2004-01-21
  • Method for Preparing 4-[9-(6-Aminopurine)]-2-(S)-Hydroxyl-Butyric Acid Methyl Ester
    申请人:Nan Fajun
    公开号:US20110201810A1
    公开(公告)日:2011-08-18
    The present invention discloses a novel method for preparing and purifying 4-(6-Amino-purin-9-yl)-2(S)-hydroxy-butyric acid methyl ester. The preparation started from cheap and easily available L-malic acid, which was transformed to intermediate I after simultaneous protection of the groups of 1-carboxyl and 2-hydroxyl. The intermediate I was selectively reduced to intermediate alcohol II, whose hydroxyl group was further transformed to an easily leaving group to afford intermediate III. The intermediate III was nucleophilically substituted with adenine to afford intermediate IV. The intermediate IV was deprotected and methyl-esterified simultaneously in methanol in the presence of an acid or a base to afford crude 4-(6-Amino-purin-9-yl)-2(S)-hydroxy-butyric acid methyl ester, which was purified by recrystallization to afford the purified product. Comparing with the prior preparation methods, the present method has advantages in low cost, mild conditions, high retention of the chiral center during the reaction, high productivity, great improvement in the quality and yield of the product and great decrease in cost, and thus is suitable for the production on a large scale.
查看更多